Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathan

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
BMJ Innovations|October 16, 2018
Development and evaluation of a novel Vital Signs Alert device for use in pregnancy in low-resource settingsHannah L Nathan, Nicola Vousden, Elodie Lawley, et al.
BMC Pregnancy and Childbirth|April 29, 2018
Evaluation of a novel vital sign device to reduce maternal mortality and morbidity in low-resource settings: a mixed method feasibility study for the CRADLE-3 trialNicola Vousden, Elodie Lawley, Hannah L Nathan, et al.
JCI Insight|January 9, 2024
The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directionsShashwat Tripathi, Cody L Nathan, Matthew C Tate, et al.
Plos One|May 31, 2017
Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugateSujiet Puthenveetil, Haiyin He, Frank Loganzo, et al.
Trials|March 29, 2018
Evaluation of a novel device for the management of high blood pressure and shock in pregnancy in low-resource settings: study protocol for a stepped-wedge cluster-randomised controlled trial (CRADLE-3 trial)Hannah L Nathan, Kate Duhig, Nicola Vousden, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
The identification and optimization of 2,4-diketobutyric acids as flap endonuclease 1 inhibitorsL Nathan Tumey, Bayard Huck, Elizabeth Gleason, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitorsL Nathan Tumey, David Bom, Bayard Huck, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosaKhisimuzi E Mdluli, Pamela R Witte, Toni Kline, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2014
Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4L Nathan Tumey, Diane H Boschelli, Niala Bhagirath, et al.
Reproductive Health|January 7, 2018
The CRADLE vital signs alert: qualitative evaluation of a novel device designed for use in pregnancy by healthcare workers in low-resource settingsHannah L Nathan, Helena Boene, Khatia Munguambe, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
BMJ Innovations|October 16, 2018
Development and evaluation of a novel Vital Signs Alert device for use in pregnancy in low-resource settingsHannah L Nathan, Nicola Vousden, Elodie Lawley, et al.
BMC Pregnancy and Childbirth|April 29, 2018
Evaluation of a novel vital sign device to reduce maternal mortality and morbidity in low-resource settings: a mixed method feasibility study for the CRADLE-3 trialNicola Vousden, Elodie Lawley, Hannah L Nathan, et al.
JCI Insight|January 9, 2024
The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directionsShashwat Tripathi, Cody L Nathan, Matthew C Tate, et al.
Plos One|May 31, 2017
Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugateSujiet Puthenveetil, Haiyin He, Frank Loganzo, et al.
Trials|March 29, 2018
Evaluation of a novel device for the management of high blood pressure and shock in pregnancy in low-resource settings: study protocol for a stepped-wedge cluster-randomised controlled trial (CRADLE-3 trial)Hannah L Nathan, Kate Duhig, Nicola Vousden, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
The identification and optimization of 2,4-diketobutyric acids as flap endonuclease 1 inhibitorsL Nathan Tumey, Bayard Huck, Elizabeth Gleason, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitorsL Nathan Tumey, David Bom, Bayard Huck, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosaKhisimuzi E Mdluli, Pamela R Witte, Toni Kline, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2014
Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4L Nathan Tumey, Diane H Boschelli, Niala Bhagirath, et al.
Reproductive Health|January 7, 2018
The CRADLE vital signs alert: qualitative evaluation of a novel device designed for use in pregnancy by healthcare workers in low-resource settingsHannah L Nathan, Helena Boene, Khatia Munguambe, et al.
Pageof 17